{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/ja/tweet/1425640656245075975","result":{"data":{"site":{"siteMetadata":{"title":"经济学人","author":"Buzzing.cc","description":"用中文浏览经济学人","keywords":["buzzing","经济学人"],"siteUrl":"https://economist.buzzing.cc","telegram":"@buzzingcc","iconUrl":"https://economist.buzzing.cc/avatar.jpg","defaultSocialImageUrl":null,"social":[{"name":"The Economist","url":"https://www.economist.com/","external":true},{"name":"Twitter @TheEconomist","url":"https://twitter.com/TheEconomist","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"RSS","url":"/rss.xml","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on The Economist","description":"See what's buzzing on The Economist in your native language","keywords":["buzzing","The Economist"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"RSS","url":"/en/rss.xml","external":null}]},{"title":"經濟學人","description":"用中文瀏覽經濟學人","keywords":["buzzing","經濟學人"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"RSS","url":"/zh-Hant/rss.xml","external":null}]},{"title":"エコノミスト人気の記事","description":"人気のエコノミスト記事を日本語で閲覧","keywords":["buzzing","エコノミスト"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"TweetPost-1425640656245075975","excerpt":"","body":"","slug":"/tweet/1425640656245075975","title":"Israel is offering a third dose of the Pfizer vaccine as a booster for its over-60s, in an attempt to stanch the Delta strain. Over 80% of adults have received a second dose https://t.co/VV9N0jLT88","tags":["tweet"],"date":"August 12, 2021","dateISO":"2021-08-12T04:00:48.000Z","datetime":"2021-08-12 04:00","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"1425640656245075975","provider":"Twitter","url":"https://twitter.com/TheEconomist/statuses/1425640656245075975","originalUrl":null,"imageRemote":null,"video":null,"channel":null,"channelUrl":null,"author":"The Economist","authorUrl":"https://twitter.com/TheEconomist","authorImage":null,"authorImageRemote":"https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-.jpg","authorSlug":"TheEconomist","score":151,"views":null,"sharedCount":36,"likeCount":79,"sharedContent":null,"parent":{"localize":[{"locale":"ja","full_text":"イスラエルでは、60歳以上の高齢者を対象に、デルタ株を阻止するために、ファイザー社製の3回目のワクチンを接種しています。成人の80％以上が2回目の接種を受けています。https://t.co/VV9N0jLT88","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"以色列正在为60岁以上的人提供第三剂量的辉瑞疫苗作为加强剂，以试图抑制三角洲菌株。超过80%的成年人已经接受了第二剂https://t.co/VV9N0jLT88。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"以色列正在爲60歲以上的人提供第三劑量的輝瑞疫苗作爲加強劑，以試圖抑制三角洲菌株。超過80%的成年人已經接受了第二劑https://t.co/VV9N0jLT88。","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"previous":{"id":"TweetPost-1425611009507614726","excerpt":"","slug":"/tweet/1425611009507614726","title":"Moderna has become synonymous with the fight against covid-19 through its ingenious mRNA vaccine. This has also brought attention to America’s wider biotechnology industry   https://t.co/B2J6balaCs","date":"August 12, 2021","__typename":"SocialMediaPost","provider":"Twitter","parent":{"localize":[{"locale":"ja","full_text":"モデナは、独創的なmRNAワクチンによって、コヴィド-19との闘いの代名詞となりました。これにより、アメリカの広範なバイオテクノロジー産業にも注目が集まりました。https://t.co/B2J6balaCs","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"Moderna通过其巧妙的mRNA疫苗成为对抗covid-19的代名词。这也使人们注意到美国更广泛的生物技术产业https://t.co/B2J6balaCs。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"Moderna通過其巧妙的mRNA疫苗成爲對抗covid-19的代名詞。這也使人們注意到美國更廣泛的生物技術產業https://t.co/B2J6balaCs。","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"next":{"id":"TweetPost-1425661437377142788","excerpt":"","slug":"/tweet/1425661437377142788","title":"In 2019, 14.6% of Harvard’s first-year students had a parent who attended as an undergraduate. Only 2% did at MIT, which has no legacy preference https://t.co/gRiJhIt8TL","__typename":"SocialMediaPost","date":"August 12, 2021","provider":"Twitter","parent":{"localize":[{"locale":"ja","full_text":"2019年、ハーバード大学の1年生の14.6％が、親が学部生として通っていた。レガシープリファレンスがないMITではわずか2％だった https://t.co/gRiJhIt8TL","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"2019年，14.6%的哈佛大学一年级学生的父母曾在本科阶段就读。在麻省理工学院，只有2%的人这样做，该学院没有遗产偏好https://t.co/gRiJhIt8TL。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"2019年，14.6%的哈佛大學一年級學生的父母曾在本科階段就讀。在麻省理工學院，只有2%的人這樣做，該學院沒有遺產偏好https://t.co/gRiJhIt8TL。","quoted_status_full_text":null,"retweeted_status_full_text":null}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"TweetPost-1425640656245075975","previousId":"TweetPost-1425611009507614726","nextId":"TweetPost-1425661437377142788","maxWidth":1024,"siteMetadata":null,"locale":"ja","hrefLang":"ja-JA","originalPath":"/tweet/1425640656245075975","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}